Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1CNS 1

Conditions

Wilms Tumor 1Sarcoma, Ewing 1Retinoblastoma 1Neuroblastoma 1Glioma 1

Interventions

Granulocyte Colony-Stimulating Factor 2Cyclophosphamide 2racotumomab 1pembrolizumab 1pegylated granulocyte colony-stimulating factor 1omburtamab I-131 1cixutumumab 1Topotecan 1Thiotepa 1Thalidomide 1Sirolimus 1Simvastatin 1Peripheral Blood Stem Cell Transplantation 1Melphalan 1Imatinib Mesylate 1Filgrastim 1Busulfan 1Bone Marrow Transplantation 1Biological Factors 1Amifostine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma, Ewing × racotumomab × Other solid neoplasm × Clear all
NCT01598454 2015-07-29

Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides

Laboratorio Elea Phoenix S.A.

Phase 1 Completed
15 enrolled
CNSGenitourinaryOther solid neoplasmSarcoma

Glioma, Wilms Tumor, Neuroblastoma, Retinoblastoma, Sarcoma, Ewing

Data powered by HemOnc (CC BY 4.0) Colophon âš¡